ES2526171T3 - Adsorbente de fosfato a base de hierro (III)-carbohidratos - Google Patents
Adsorbente de fosfato a base de hierro (III)-carbohidratos Download PDFInfo
- Publication number
- ES2526171T3 ES2526171T3 ES11152584.6T ES11152584T ES2526171T3 ES 2526171 T3 ES2526171 T3 ES 2526171T3 ES 11152584 T ES11152584 T ES 11152584T ES 2526171 T3 ES2526171 T3 ES 2526171T3
- Authority
- ES
- Spain
- Prior art keywords
- iii
- iron
- adsorbent
- phosphate adsorbent
- phosphate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229910019142 PO4 Inorganic materials 0.000 title abstract description 8
- 239000010452 phosphate Substances 0.000 title abstract description 8
- 239000003463 adsorbent Substances 0.000 title abstract description 7
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 title abstract 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 2
- 229930006000 Sucrose Natural products 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 2
- 229910052742 iron Inorganic materials 0.000 abstract 2
- 239000005720 sucrose Substances 0.000 abstract 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000001694 spray drying Methods 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- -1 hydroxypropyl Chemical group 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000008384 inner phase Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229940083037 simethicone Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
- B01J20/06—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising oxides or hydroxides of metals not provided for in group B01J20/04
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/223—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material containing metals, e.g. organo-metallic compounds, coordination complexes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28014—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their form
- B01J20/2803—Sorbents comprising a binder, e.g. for forming aggregated, agglomerated or granulated products
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G49/00—Compounds of iron
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G49/00—Compounds of iron
- C01G49/0018—Mixed oxides or hydroxides
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G49/00—Compounds of iron
- C01G49/02—Oxides; Hydroxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/02—Iron compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Nutrition Science (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06126101 | 2006-12-14 | ||
| EP06126122A EP1932807A1 (en) | 2006-12-14 | 2006-12-14 | Inorganic compounds |
| EP06126122 | 2006-12-14 | ||
| EP06126101 | 2006-12-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2526171T3 true ES2526171T3 (es) | 2015-01-07 |
Family
ID=38983614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES11152584.6T Active ES2526171T3 (es) | 2006-12-14 | 2007-12-05 | Adsorbente de fosfato a base de hierro (III)-carbohidratos |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US8252310B2 (enExample) |
| JP (1) | JP5456969B2 (enExample) |
| KR (1) | KR20090094820A (enExample) |
| AR (1) | AR064301A1 (enExample) |
| AU (1) | AU2007331482B2 (enExample) |
| BR (1) | BRPI0720272A2 (enExample) |
| CA (1) | CA2671828C (enExample) |
| CL (1) | CL2007003606A1 (enExample) |
| EC (1) | ECSP099410A (enExample) |
| ES (1) | ES2526171T3 (enExample) |
| IL (1) | IL198548A0 (enExample) |
| MA (1) | MA30993B1 (enExample) |
| MX (1) | MX2009006307A (enExample) |
| MY (1) | MY151047A (enExample) |
| NO (1) | NO342285B1 (enExample) |
| NZ (1) | NZ576672A (enExample) |
| PE (1) | PE20081381A1 (enExample) |
| PT (1) | PT2319804E (enExample) |
| RU (1) | RU2447933C2 (enExample) |
| SI (1) | SI2319804T1 (enExample) |
| TN (1) | TN2009000214A1 (enExample) |
| TW (1) | TWI465239B (enExample) |
| WO (1) | WO2008071747A1 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9720061D0 (en) | 1997-09-19 | 1997-11-19 | Crosfield Joseph & Sons | Metal compounds as phosphate binders |
| MY157620A (en) | 2006-01-31 | 2016-06-30 | Cytochroma Dev Inc | A granular material of a solid water-soluble mixed metal compound capable of binding phosphate |
| GB0714670D0 (en) | 2007-07-27 | 2007-09-05 | Ineos Healthcare Ltd | Use |
| GB0720220D0 (en) | 2007-10-16 | 2007-11-28 | Ineos Healthcare Ltd | Compound |
| TWI592159B (zh) | 2007-11-16 | 2017-07-21 | 威佛（國際）股份有限公司 | 藥學組成物 |
| JP2009292119A (ja) | 2008-06-09 | 2009-12-17 | Alps Electric Co Ltd | サーマルヘッド |
| WO2009150232A2 (en) * | 2008-06-13 | 2009-12-17 | Novartis Ag | Manufacture process for the preparation of an iron containing phosphate adsorbent |
| GB0814326D0 (en) * | 2008-08-05 | 2008-09-10 | Medical Res Council | Phosphate binding materials and their uses |
| CN102573807A (zh) | 2009-07-21 | 2012-07-11 | 凯克斯生物制药公司 | 柠檬酸铁剂型 |
| GB0913525D0 (en) | 2009-08-03 | 2009-09-16 | Ineos Healthcare Ltd | Method |
| GB201001779D0 (en) | 2010-02-04 | 2010-03-24 | Ineos Healthcare Ltd | Composition |
| DE102011112898A1 (de) | 2011-09-08 | 2013-03-14 | Charité - Universitätsmedizin Berlin | Nanopartikuläres Phosphatadsorbens basierend auf Maghämit oder Maghämit/Magnetit, dessen Herstellung und Verwendungen |
| CA2849926C (en) * | 2011-10-13 | 2020-07-21 | Vidasym, Inc. | Iron-fiber composition, preparation and uses thereof |
| RU2496722C1 (ru) * | 2012-04-10 | 2013-10-27 | Леонид Асхатович Мазитов | Способ очистки сточной воды от фосфатов |
| CN109497565B (zh) | 2013-03-08 | 2021-10-26 | 上海礼邦医药科技有限公司 | 金属离子-功能性纤维组分络合物组合物、其制备及用途 |
| HK1216513A1 (zh) * | 2013-03-15 | 2016-11-18 | 阿普雷奇亚制药有限责任公司 | 包含左乙拉西坦的快速分散劑型 |
| US9339489B2 (en) * | 2013-03-15 | 2016-05-17 | Aprecia Pharmaceuticals Company | Rapid disperse dosage form containing levetiracetam |
| WO2015078900A1 (en) | 2013-11-27 | 2015-06-04 | Vifor (International) Ag | Pharmaceutical composition, comprising phosphate binder particles |
| US10172882B2 (en) | 2014-06-22 | 2019-01-08 | Dexcel Pharma Technologies Ltd. | Pharmaceutical compositions comprising ferric citrate and methods for the production thereof |
| US9901918B2 (en) * | 2015-03-04 | 2018-02-27 | Graver Technologies Llc | Hybrid ion exchange material and method for making the same |
| CN105193844A (zh) * | 2015-05-27 | 2015-12-30 | 合肥川迪医药技术有限公司 | 用于制备含δ-羟基氧化铁(多核)及其药物组合物的方法及在高磷血症领域中的应用 |
| WO2017172633A1 (en) * | 2016-03-28 | 2017-10-05 | New Sky Energy Intellectual Property Holding Company, Llc | Methods of producing ferrihydrite nanoparticle slurries, and systems and products employing the same |
| WO2020025552A1 (en) | 2018-07-30 | 2020-02-06 | Interquim, S.A. | Process for preparing an adsorbent for phosphate in aqueous medium |
| CN115175670B (zh) * | 2020-01-16 | 2024-08-30 | 威佛费森尤斯医疗肾脏药物有限公司 | 羟基氧化铁(iii)、蔗糖和一种或更多种淀粉的混合物的颗粒，优选羟基氧化蔗糖铁的颗粒 |
| CN115317494B (zh) * | 2022-07-22 | 2024-02-13 | 康瑞鑫(天津)药物研究院有限公司 | 高磷酸盐结合力的蔗糖氢氧化氧铁及其制备方法 |
| WO2025096992A1 (en) * | 2023-11-01 | 2025-05-08 | Navinta, Llc | Process for isolation of solid ferric derisomaltose |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2885393A (en) * | 1956-02-24 | 1959-05-05 | R K Laros Company | Dextran-iron complex and process for making same |
| US3697502A (en) * | 1969-11-03 | 1972-10-10 | Christensen Henry M | Method of making iron dextran-preparations |
| US3951821A (en) * | 1972-07-14 | 1976-04-20 | The Dow Chemical Company | Disintegrating agent for tablets |
| US4180567A (en) * | 1977-09-02 | 1979-12-25 | Pharmachem Corporation | Iron preparations and methods of making and administering the same |
| DE3026868C2 (de) * | 1980-07-16 | 1986-03-13 | Laboratorien Hausmann AG, St. Gallen | Verfahren zur Herstellung von Eisen(III)hydroxid-Dextran-Komplexen und sie enthaltende pharmazeutische sterile wäßrige Lösung |
| US4569836A (en) * | 1981-08-27 | 1986-02-11 | Gordon Robert T | Cancer treatment by intracellular hyperthermia |
| EP0330801A1 (en) * | 1983-02-08 | 1989-09-06 | Schering Aktiengesellschaft | Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease |
| DE3422249A1 (de) * | 1984-06-15 | 1985-12-19 | Pfeifer & Langen, 5000 Köln | Wasserloesliches eisendextran und verfahren zu seiner herstellung |
| DE3572440D1 (en) * | 1984-06-19 | 1989-09-28 | Basf Ag | Gastro-resistant cylindrical pancreatine-microtablets |
| US4827945A (en) * | 1986-07-03 | 1989-05-09 | Advanced Magnetics, Incorporated | Biologically degradable superparamagnetic materials for use in clinical applications |
| US5055288A (en) * | 1987-06-26 | 1991-10-08 | Advanced Magnetics, Inc. | Vascular magnetic imaging method and agent comprising biodegradeable superparamagnetic metal oxides |
| US4970079A (en) * | 1989-06-05 | 1990-11-13 | Purdue Research Foundation | Method and composition of oxy-iron compounds for treatment of hyperphosphatemia |
| IL98744A0 (en) * | 1990-07-06 | 1992-07-15 | Gen Hospital Corp | Method of studying biological tissue using monocrystalline particles |
| SU1807606A1 (ru) * | 1991-03-29 | 1995-08-09 | Пермский политехнический институт | Способ получения анионообменника на основе гидроксида титана |
| US5234697A (en) * | 1992-06-22 | 1993-08-10 | Digestive Care Inc. | Compositions of gastric acid-resistant microspheres containing salts of bile acids |
| DE69320120T2 (de) | 1992-09-04 | 1999-04-08 | Mitsubishi Chemical Corp., Tokio/Tokyo | Verfahren zur Herstellung und Verwendung eines Anionen- austauscherharzes |
| DE4239442C2 (de) * | 1992-11-24 | 2001-09-13 | Sebo Gmbh | Verwendung eines mit polynuklearen Metalloxidhydroxiden modifizierten Adsorptionsmaterials zur selektiven Elimination von anorganischem Phosphat aus proteinhaltigen Flüssigkeiten |
| DE19547356A1 (de) * | 1995-12-19 | 1997-06-26 | Vifor Int Ag | Adsorbens für Phosphat aus wäßrigem Medium, dessen Herstellung und Verwendung |
| US5906978A (en) * | 1996-08-14 | 1999-05-25 | Hemocleanse, Inc. | Method for iron delivery to a patient by transfer from dialysate |
| GB9720061D0 (en) | 1997-09-19 | 1997-11-19 | Crosfield Joseph & Sons | Metal compounds as phosphate binders |
| DE10128511A1 (de) * | 2001-06-13 | 2002-12-19 | Sebo Gmbh | Verwendung eines Phosphatadsorbers gegen Gefäßerkrankungen |
| WO2003053565A1 (en) * | 2001-12-21 | 2003-07-03 | Muromachi Chemical Co., Ltd. | Adsorbent for phosphoric acid |
| DE102004031181A1 (de) | 2004-06-28 | 2006-01-19 | Vifor (International) Ag | Phosphatadsorbens |
-
2007
- 2007-12-05 SI SI200731582T patent/SI2319804T1/sl unknown
- 2007-12-05 PT PT111525846T patent/PT2319804E/pt unknown
- 2007-12-05 ES ES11152584.6T patent/ES2526171T3/es active Active
- 2007-12-10 US US12/001,132 patent/US8252310B2/en active Active
- 2007-12-12 CA CA2671828A patent/CA2671828C/en active Active
- 2007-12-12 MY MYPI20092071 patent/MY151047A/en unknown
- 2007-12-12 CL CL200703606A patent/CL2007003606A1/es unknown
- 2007-12-12 PE PE2007001773A patent/PE20081381A1/es not_active Application Discontinuation
- 2007-12-12 AR ARP070105565A patent/AR064301A1/es not_active Application Discontinuation
- 2007-12-12 WO PCT/EP2007/063832 patent/WO2008071747A1/en not_active Ceased
- 2007-12-12 MX MX2009006307A patent/MX2009006307A/es active IP Right Grant
- 2007-12-12 RU RU2009126614/05A patent/RU2447933C2/ru active
- 2007-12-12 BR BRPI0720272-5A patent/BRPI0720272A2/pt not_active Application Discontinuation
- 2007-12-12 AU AU2007331482A patent/AU2007331482B2/en active Active
- 2007-12-12 NZ NZ576672A patent/NZ576672A/en unknown
- 2007-12-12 KR KR1020097012145A patent/KR20090094820A/ko not_active Ceased
- 2007-12-13 JP JP2007322260A patent/JP5456969B2/ja active Active
- 2007-12-13 TW TW096147736A patent/TWI465239B/zh active
-
2009
- 2009-05-04 IL IL198548A patent/IL198548A0/en unknown
- 2009-05-29 TN TNP2009000214A patent/TN2009000214A1/fr unknown
- 2009-06-12 EC EC2009009410A patent/ECSP099410A/es unknown
- 2009-06-15 MA MA31992A patent/MA30993B1/fr unknown
- 2009-07-10 NO NO20092632A patent/NO342285B1/no unknown
-
2012
- 2012-02-03 US US13/365,349 patent/US20120126440A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0720272A2 (pt) | 2014-01-28 |
| MX2009006307A (es) | 2009-06-23 |
| ECSP099410A (es) | 2009-07-31 |
| HK1133248A1 (en) | 2010-03-19 |
| JP2008150375A (ja) | 2008-07-03 |
| MA30993B1 (fr) | 2009-12-01 |
| NO20092632L (no) | 2009-07-14 |
| WO2008071747A1 (en) | 2008-06-19 |
| KR20090094820A (ko) | 2009-09-08 |
| SI2319804T1 (sl) | 2015-01-30 |
| PT2319804E (pt) | 2014-11-24 |
| CA2671828C (en) | 2012-06-19 |
| US8252310B2 (en) | 2012-08-28 |
| IL198548A0 (en) | 2010-02-17 |
| TWI465239B (zh) | 2014-12-21 |
| TW200831115A (en) | 2008-08-01 |
| AU2007331482A1 (en) | 2008-06-19 |
| CA2671828A1 (en) | 2008-06-19 |
| JP5456969B2 (ja) | 2014-04-02 |
| NO342285B1 (no) | 2018-04-30 |
| CL2007003606A1 (es) | 2008-07-18 |
| AU2007331482B2 (en) | 2011-04-21 |
| US20120126440A1 (en) | 2012-05-24 |
| PE20081381A1 (es) | 2008-11-12 |
| US20080145410A1 (en) | 2008-06-19 |
| AR064301A1 (es) | 2009-03-25 |
| MY151047A (en) | 2014-03-31 |
| TN2009000214A1 (en) | 2010-10-18 |
| NZ576672A (en) | 2012-02-24 |
| RU2009126614A (ru) | 2011-01-20 |
| RU2447933C2 (ru) | 2012-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2526171T3 (es) | Adsorbente de fosfato a base de hierro (III)-carbohidratos | |
| US5399700A (en) | Method for preparing enteric-coated oral drugs containing acid-unstable compounds | |
| KR850000242A (ko) | 작용 지속형 세파클로르 제제의 제조방법 | |
| JP2009544617A5 (enExample) | ||
| KR20220101604A (ko) | 제약학적 공융 염 제제 | |
| US20250313531A1 (en) | Formulated and/or Co-Formulated Liposome Compositions Containing IDO Antagonist Prodrugs Useful in the Treatment of Cancer and Methods Thereof | |
| Ha et al. | A colon-targeted podophyllotoxin nanoprodrug: Synthesis, characterization, and supramolecular hydrogel formation for the drug combination | |
| CN109562060A (zh) | 混合粘膜粘着剂递送体系和其用途 | |
| US7682629B1 (en) | Floating pharmaceutical composition comprising an active phase and a non-active phase | |
| CN102716082A (zh) | 一种头孢西丁钠脂质体注射剂 | |
| CN102038640B (zh) | 一种含有胆固醇的peg修饰物的脂质体药物及其制备方法 | |
| CN114901275A (zh) | 可用于治疗癌症的含有Toll样受体(“TLR”)激动剂前药的配制和/或共同配制的脂质体组合物及其方法 | |
| WO2012044761A1 (en) | Ladder-frame polyether conjugates | |
| CN102366410A (zh) | 一种阿加曲班脂质体注射剂 | |
| CN101401799A (zh) | 花粉微囊药物制备方法 | |
| US20250032620A1 (en) | Formulated and/or Co-Formulated Nanocarrier Compositions Containing TFGß Antagonist Prodrugs Useful in the Treatment of Cancer and Methods Thereof | |
| WO2024094125A1 (en) | Lipid compounds, lipid nanoparticles, and pharmaceutical compositions | |
| FI117865B (fi) | Lääkeainesuoloja | |
| AU2014205324A1 (en) | Vitamins C and K for treating polycystic diseases | |
| CN107198683B (zh) | 一种法呢基乙酸香叶醇酯药物组合物及其制备方法和用途 | |
| CN108299499A (zh) | 一种pH敏感的磷脂酰乙醇胺分子及其制备方法 | |
| WO2025058654A1 (en) | Formulated and/or co-formulated liposome compositions containing tgfb antagonist prodrugs useful in the treatment of cancer and methods thereof | |
| JP2023541389A (ja) | がんの処置において有用なｐｄ－１アンタゴニストプロドラッグを含有する製剤化および／または共製剤化リポソーム組成物ならびにその方法 | |
| CN116869936A (zh) | 一种氧化还原敏感性紫草素脂质体及其制备方法和用途 | |
| JP2024510613A (ja) | がんの処置に有用なＡ２ａＲアンタゴニストプロドラッグを含有する製剤化および／または共製剤化されたリポソーム組成物ならびにその方法 |